REQUEST A DEMO
Total
USD $0.00
Search more companies

Novotech Clinical Research (Romania) S.R.L. (Romania)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Novotech Clinical Research (Romania) S.R.L. Profile Updated: April 21, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Novotech Clinical Research (Romania) S.R.L. is an enterprise located in Romania, with the main office in Bucharest. The enterprise currently operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) sector. The company was established on November 12, 2009. It currently has a total number of 19 (2025) employees. In 2025, the company reported a net sales revenue drop of 7.65%. Its’ total assets recorded a growth of 9.68%. The net profit margin of Novotech Clinical Research (Romania) S.R.L. increased by 0.79% in 2025.

Headquarters
Strada Tudor Arghezi Nr. 21
Bucharest; Bucharest; Postal Code: 020943

Contact Details: Purchase the Novotech Clinical Research (Romania) S.R.L. report to view the information.

Basic Information
Total Employees:
Purchase the Novotech Clinical Research (Romania) S.R.L. report to view the information.
Registered Capital:
Purchase the Novotech Clinical Research (Romania) S.R.L. report to view the information.
Financial Auditors:
Purchase the Novotech Clinical Research (Romania) S.R.L. report to view the information.
Incorporation Date:
November 12, 2009
Key Executives
Purchase this report to view the information.
Administrator
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Novotech Clinical Research (Romania) S.R.L. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Net sales revenue
-7.65%
Total Operating Revenue
-7.65%
Operating Profit
16.28%
EBITDA
10.46%
Net Profit/Loss for the Period
31.2%
Total Assets
9.68%
Total Equity
24.29%
Operating Profit Margin
0.92%
Net Profit Margin
0.79%
Return on Equity (ROE)
1.02%
Quick Ratio
0.26%
Cash Ratio
0.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?